Expertise in
3
conditions

Dr. Michael E. Gottschalk

Pediatric Endocrinology
Office
3030 Childrens Way, 
San Diego, CA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
3
conditions
Office
3030 Childrens Way, 
San Diego, CA 

Overview

Michael Gottschalk is a Pediatric Endocrinologist practicing medicine in San Diego, California.

Dr. Gottschalk is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Type A Insulin Resistance Syndrome, Acanthosis Nigricans, and Precocious Puberty.

He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 9 clinical trials. Dr. Gottschalk is currently accepting new patients.

Specialties

Pediatric Endocrinology

Licenses

Pediatric Endocrinology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 10 Less Insurance Carriers -

Locations

Office
3030 Childrens Way, San Diego, CA 92123

Additional Areas of Focus

Dr. Gottschalk has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: June 17, 2026
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
Post-operative Methylprednisolone Taper Course for Orthopedic Surgery
Post-operative Methylprednisolone Taper Course for Orthopedic Surgery
Enrollment Status: Enrolling_by_invitation
Publish Date: March 12, 2026
Intervention Type: Drug, Other
Study Drugs: Dexamethasone, Methylprednisolone
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
Enrollment Status: Completed
Publish Date: September 26, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
Enrollment Status: Completed
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
Corticosteroid(CS) Injections for the Treatment of Common Upper Extremity Pathologies, With or Without Lidocaine
Corticosteroid(CS) Injections for the Treatment of Common Upper Extremity Pathologies, With or Without Lidocaine
Enrollment Status: Terminated
Publish Date: October 12, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 7 Less Clinical Trials

19 Total Publications

Correlation Between Technology and Improved Outcomes in Youth With Type 1 Diabetes Mellitus: Prospective Study Examining Outcomes for Patients With Depression and Those With Public Insurance.
Correlation Between Technology and Improved Outcomes in Youth With Type 1 Diabetes Mellitus: Prospective Study Examining Outcomes for Patients With Depression and Those With Public Insurance.
Journal: JMIR diabetes
Published: December 20, 2024
Similar Doctors
Expertise in
15
conditions
Dr. Ximena P. Lopez
Pediatric Endocrinology
Expertise in
15
conditions
Dr. Ximena P. Lopez
Pediatric Endocrinology
Referral may be required
Before you request

Office

3030 Childrens Way, 
San Diego, CA 
 (0.1 miles away)
858-966-4032
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ximena Lopez is a Pediatric Endocrinologist practicing medicine in San Diego, California. Dr. Lopez is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), Familial Short Stature (FSS), and Congenital Hypothyroidism. Dr. Lopez is currently accepting new patients.

Expertise in
2
conditions
Dr. Carla Demeterco-Berggren
Pediatric Endocrinology
Expertise in
2
conditions
Dr. Carla Demeterco-Berggren
Pediatric Endocrinology
Referral may be required
Before you request

Rady Children's Hospital San Diego

3020 Childrens Way, 
San Diego, CA 
 (0.1 miles away)
858-966-4032
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carla Demeterco-Berggren is a Pediatric Endocrinologist practicing medicine in San Diego, California. Dr. Demeterco-Berggren is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Diabetic Ketoacidosis, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Short Stature (Growth Disorders). Dr. Demeterco-Berggren is currently accepting new patients.

Expertise in
3
conditions
Dr. Ron S. Newfield
Pediatric Endocrinology
Expertise in
3
conditions
Dr. Ron S. Newfield
Pediatric Endocrinology
Referral may be required
Before you request

Rady Children's Hospital San Diego

3020 Childrens Way, 
San Diego, CA 
 (0.1 miles away)
858-966-4032
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ron Newfield is a Pediatric Endocrinologist practicing medicine in San Diego, California. Dr. Newfield is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Short Stature (Growth Disorders), Intersex, Malnutrition, and Thyroidectomy. Dr. Newfield is currently accepting new patients.

Frequently Asked Questions about Dr. Michael E. Gottschalk

How do I make an appointment with Dr. Michael E. Gottschalk?

You can book an appointment with Dr. Michael E. Gottschalk by calling their office at 858-966-4032. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael E. Gottschalk a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael E. Gottschalk is classified as an Advanced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael E. Gottschalk specialize in?

While Dr. Michael E. Gottschalk is a Pediatric Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Type A Insulin Resistance Syndrome, and Acanthosis Nigricans. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Michael E. Gottschalk participate in research or clinical trials?

Yes. Dr. Michael E. Gottschalk has published 19 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. Michael E. Gottschalk's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael E. Gottschalk accept my insurance?

Dr. Michael E. Gottschalk accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 858-966-4032 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gottschalk's expertise for a condition
ConditionClose
      View All 29 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile